Cargando…
Inhibition of Angiogenesis by Rhizoxin, a Microbial Metabolite Containing Two Epoxide Groups
Previous studies by our and other groups have shown that microbial products containing more than one epoxide group, including eponemycin, radicicol, depudecin and AGM‐1470, exhibit anti‐angio‐genic activity in an in vivo assay system involving chorioallantoic membranes (CAMs) of growing chick embryo...
Autores principales: | Onozawa, Chizuko, Shimamura, Mariko, Iwasaki, Shigeo, Oikawa, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921335/ https://www.ncbi.nlm.nih.gov/pubmed/9473728 http://dx.doi.org/10.1111/j.1349-7006.1997.tb00339.x |
Ejemplares similares
-
Okadaic Acid Is a Potent Angiogenesis Inducer
por: Oikawa, Tsutomu, et al.
Publicado: (1992) -
Ring-Closing Metathesis Approaches towards the Total Synthesis of Rhizoxins
por: Liniger, Marc, et al.
Publicado: (2020) -
Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.
por: Hanauske, A. R., et al.
Publicado: (1996) -
Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancer.
por: Kerr, D. J., et al.
Publicado: (1995) -
Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group.
por: Verweij, J., et al.
Publicado: (1996)